Experience the science-backed difference of our advanced liposomal products today
requires medical knowledge to minimize risk Intranasal Intranasal delivery to target the olfactory bulb and trans-cribriform access to the brain has been explored for some peptides: Theoretical advantage: Direct CNS access, bypassing the blood-brain barrier Reality: Intranasal peptide formulations are complex and Dihexa is not commonly available in this form Evidence: No published data on intranasal Dihexa efficacy or safety Oral Bioavailability: Approximately 38% The most commonly cited bioavailability figure for oral Dihexa is approximately 38%
GLOW Blend Peptide Representative Literature (Independent Cytoskeletal / ECM-Associated / Metallopeptide / Endothelial-Linked Research | Research Use Only) The publications listed below provide general scientific context on actin-associated signaling, matrix-regulation pathways, copper-dependent enzymatic mechanisms, and endothelial-linked cellular responses
Evidence Based Research This article has been researched and written based on scientific evidence and fact sheets that have then been crossed checked by our team of doctors and subject matter experts
(4) mGPDH: Mitochondrial glycerol-3-phosphate (G3P) dehydrogenase (mGPDH, also known as GPD2) is a flavoprotein located in the inner mitochondrial membrane and serves as a key enzyme in the glycerol phosphate shuttle 54
Up to 40% of weight lost on these medications may be muscle, which can weaken the body, slow metabolism, and impair function